Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study

We determined first- and second-line regimens, including hematopoietic stem cell transplantations, in all diffuse large B cell lymphoma (DLBCL) patients aged ≥20 yr (n = 1,888), registered at the Belgian Cancer Registry (2013–2015). Treatments were inferred from reimbursed drugs, and procedures regi...

Descripción completa

Detalles Bibliográficos
Autores principales: Daneels, Willem, Rosskamp, Michael, Macq, Gilles, Saadoon, Estabraq Ismael, De Geyndt, Anke, Offner, Fritz, Poirel, Hélène A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922541/
https://www.ncbi.nlm.nih.gov/pubmed/35299736
http://dx.doi.org/10.3389/fonc.2022.824704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922541/
https://www.ncbi.nlm.nih.gov/pubmed/35299736
http://dx.doi.org/10.3389/fonc.2022.824704

Ejemplares similares